HMGCR and glioblastoma: The production of lipid moieties required for the replication in GBM cells is primarily based on the MVA pathway; thus, GBM cell replication and development is inherently susceptible to statins functioning as competitive inhibitors of HMG-CoA reductase enzyme, which controls MVA production [7].